Sack Lunch Productions announces The Lantern Festival® Salt Lake City rescheduled.
Sep 22, 2017 18:59 pm UTC| Business
Salt Lake City, Sept. 22, 2017 -- Sack Lunch Productions announces The Lantern Festival® Salt Lake City: Event Rescheduled for September 30th. ...
Nasdaq Welcomes Secoo Holding Limited (Nasdaq: SECO) to The Nasdaq Global Market
Sep 22, 2017 18:57 pm UTC| Business
NEW YORK, Sept. 22, 2017 -- Secoo Holding Limited (Nasdaq:SECO), Asia's largest online integrated upscale products and services platform, rang the opening bell at the Nasdaq MarketSite in Times Square today in...
CareFirst BlueCross BlueShield Announces Planned Retirement of President & CEO Chet Burrell
Sep 22, 2017 18:29 pm UTC| Business
Baltimore, Md., Sept. 22, 2017 -- CareFirst BlueCross BlueShield (CareFirst) today announced that Chet Burrell will retire as President CEO in mid-2018. Burrell has held this role at the region’s largest health...
pSivida to Present at the Ladenburg Thalmann 2017 Healthcare Conference
Sep 22, 2017 18:29 pm UTC| Business
WATERTOWN, Mass., Sept. 22, 2017 -- pSivida Corp. (NASDAQ:PSDV) (ASX:PVA), a leader in the development of sustained release drug products and technologies, today announced that Nancy Lurker, President and Chief...
Chief Outsiders to Provide Marketing Insights in Partnership with Rhythm Systems
Sep 22, 2017 18:24 pm UTC| Business
Houston, TX, Sept. 22, 2017 -- Chief Outsiders – the nation’s leading “Executives-as-a-Service” firm devoted to the growth of small and mid-market businesses – will partner with Rhythm Systems on a pair of initiatives...
Trevena To Present at the Ladenburg Thalmann 3rd Annual 2017 Healthcare Conference
Sep 22, 2017 18:09 pm UTC| Business
CHESTERBROOK, Pa., Sept. 22, 2017 -- Trevena, Inc. (NASDAQ:TRVN) today announced that it will be presenting at the 3rd Annual 2017 Healthcare Conference hosted by Ladenburg Thalmann on Tuesday, September 26, 2017, at...
Sep 22, 2017 17:54 pm UTC| Business
AUSTIN, Texas, Sept. 22, 2017 -- Molecular Templates, Inc., (Nasdaq:MTEM) a clinical stage biopharmaceutical company focused on the discovery and development of Engineered Toxin Bodies (ETBs), a new class of targeted...